New York, NY -- (SBWIRE) -- 10/03/2013 -- StockMarketIntel.com issues a special report on the following stocks: TOUR GOLD CORP (OTCMKTS: DRGDF), Titan Pharmaceuticals, Inc.(OTCBB:TTNP), TELECORP INC(OTCMKTS:TLNUF), Generex Biotechnology Corporation (OTCMKTS: GNBT)
DETOUR GOLD CORP (OTCMKTS: DRGDF) recently declined 3.69%, while trading on 99,660.00 shares at the price of $ 38,808.00. If we look at its trading history of the past 52 weeks, the share price suffered a low of $6.90 and was moved to its maximum level of $29.96.The stock changed hands in a range of $8.20 to $8.71, bringing its market capitalization at about $1.12 billion. Detour Gold Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada.
For How Long DRGDF will fight for Profitability? Read This Trend Analysis report
Titan Pharmaceuticals, Inc.(OTCBB:TTNP) added 11.59% recently, at the price of $0.770. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.32 and was moved to its maximum level of $2.53.The stock changed hands in a range of $0.70 to $0.79, bringing its market capitalization at about $63.56 million. Alternative Energy Partners, Inc., a development stage company, engages in the energy production and management business in the United States.
For How Long TTNP’s Gloss will Attract Investors? Find out via this report
TELECORP INC(OTCMKTS:TLNUF) recently declined -32.69% and was moving within a range of $0.03-$0.06, its current trading price is $0.0350. The stock is moving up till now with a total volume of 1.19 M shares, versus an average volume of 252,151.00 shares. The share price hit its 52-week low of $0.02 and $0.62 was the best price. Telecorp, Inc. provides automated voice services, emergency communications, conferencing, data management, webinars, customer and hardware support tools, e-mail, fax and text broadcast messaging, direct to voice mail messaging, customized voice messaging, text to speech systems, predictive and progressive dialing, contact management solutions as well as IT services (SaaS and CRM).
Will TLNUF Get Buyers Even After The Recent Rally? Find Out Here
Generex Biotechnology Corporation (OTCMKTS: GNBT) declined 4.92% in its current trading activity, bringing its market capitalization around $1.62 million. The total number of shares that changed hands during the current session up till now was 1.62M shares, as compared to average trading volume of 1.83M shares. The share price after opening at $0.03 made a high of $0.03 and hovered above $0.03, while its recent trading price was $0.0320. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)